BACKGROUND: White matter (WM) abnormalities have been implicated in schizophrenia, yet the mechanisms underlying these abnormalities are not fully understood. Several lines of evidence suggest that polyunsaturated fatty acids (PUFAs) play a role in myelination, and there is substantial evidence documenting decreased PUFA concentrations in schizophrenia. We therefore hypothesized that lower membrane PUFA concentrations may be related to reduced WM integrity in schizophrenia and related disorders. METHODS: In 30 male patients with a recent-onset psychotic disorder, erythrocyte membrane PUFA concentrations were assessed and diffusion tensor imaging was performed with voxelwise analysis. RESULTS: Lower total PUFA concentration was associated with lower fractional anisotropy (FA) throughout the corpus callosum and bilateral parietal, occipital, temporal and frontal WM (P < .05, corrected). Of the individual PUFAs, lower arachidonic acid concentration, and to a lesser extent, lower nervonic acid, linoleic acid, and docosapentaenoic acid concentration were significantly associated with lower FA. PUFA concentrations were inversely associated with radial diffusivity but showed little association with axial diffusivity. Greater severity of negative symptoms was associated with lower nervonic acid concentration and lower FA values. CONCLUSIONS: Membrane PUFA concentrations appear to be robustly related to brain WM integrity in early phase psychosis. These findings may provide a basis for studies to investigate the effects of PUFA supplementation on WM integrity and associated symptomatology in early psychosis.
BACKGROUND:White matter (WM) abnormalities have been implicated in schizophrenia, yet the mechanisms underlying these abnormalities are not fully understood. Several lines of evidence suggest that polyunsaturated fatty acids (PUFAs) play a role in myelination, and there is substantial evidence documenting decreased PUFA concentrations in schizophrenia. We therefore hypothesized that lower membrane PUFA concentrations may be related to reduced WM integrity in schizophrenia and related disorders. METHODS: In 30 male patients with a recent-onset psychotic disorder, erythrocyte membrane PUFA concentrations were assessed and diffusion tensor imaging was performed with voxelwise analysis. RESULTS: Lower total PUFA concentration was associated with lower fractional anisotropy (FA) throughout the corpus callosum and bilateral parietal, occipital, temporal and frontal WM (P < .05, corrected). Of the individual PUFAs, lower arachidonic acid concentration, and to a lesser extent, lower nervonic acid, linoleic acid, and docosapentaenoic acid concentration were significantly associated with lower FA. PUFA concentrations were inversely associated with radial diffusivity but showed little association with axial diffusivity. Greater severity of negative symptoms was associated with lower nervonic acid concentration and lower FA values. CONCLUSIONS: Membrane PUFA concentrations appear to be robustly related to brain WM integrity in early phase psychosis. These findings may provide a basis for studies to investigate the effects of PUFA supplementation on WM integrity and associated symptomatology in early psychosis.
Authors: G P Amminger; M R Schäfer; C M Klier; J-M Slavik; I Holzer; M Holub; S Goldstone; T J Whitford; P D McGorry; M Berk Journal: Mol Psychiatry Date: 2011-12-20 Impact factor: 15.992
Authors: Matthan W A Caan; Ganesh Khedoe; Dirk Poot; Arjan den Dekker; Silvia Olabarriaga; Kees Grimbergen; Lucas van Vliet; Frans Vos Journal: Med Image Comput Comput Assist Interv Date: 2010
Authors: A J Richardson; S J Allen; J V Hajnal; I J Cox; T Easton; B K Puri Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2001-11 Impact factor: 5.067
Authors: Håvard Bentsen; Dag K Solberg; Helge Refsum; Jon Michael Gran; Thomas Bøhmer; Peter A Torjesen; Ola Halvorsen; Odd Lingjærde Journal: Biol Psychiatry Date: 2011-05-05 Impact factor: 13.382
Authors: G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger Journal: Arch Gen Psychiatry Date: 2010-02
Authors: Mohammad M Khan; Denise R Evans; Vijayasudha Gunna; Russell E Scheffer; Vinay V Parikh; Sahebarao P Mahadik Journal: Schizophr Res Date: 2002-11-01 Impact factor: 4.939
Authors: Robert K McNamara; Ruth H Asch; Diana M Lindquist; Robert Krikorian Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2017-05-09 Impact factor: 4.006
Authors: Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie Journal: World Psychiatry Date: 2014-10 Impact factor: 49.548
Authors: Bart D Peters; Aristotle N Voineskos; Philip R Szeszko; Tristram A Lett; Pamela DeRosse; Saurav Guha; Katherine H Karlsgodt; Toshikazu Ikuta; Daniel Felsky; Majnu John; David J Rotenberg; James L Kennedy; Todd Lencz; Anil K Malhotra Journal: J Neurosci Date: 2014-04-30 Impact factor: 6.167
Authors: Suzanne Medema; Roel J T Mocking; Maarten W J Koeter; Frédéric M Vaz; Carin Meijer; Lieuwe de Haan; Nico J M van Beveren; René Kahn; Lieuwe de Haan; Jim van Os; Durk Wiersma; Richard Bruggeman; Wiepke Cahn; Carin Meijer; Inez Myin-Germeys Journal: Schizophr Bull Date: 2015-09-18 Impact factor: 9.306
Authors: Yian Gu; Robert S Vorburger; Yunglin Gazes; Christian G Habeck; Yaakov Stern; José A Luchsinger; Jennifer J Manly; Nicole Schupf; Richard Mayeux; Adam M Brickman Journal: Ann Neurol Date: 2016-05-11 Impact factor: 10.422
Authors: Binod Thapa Chhetry; Adrienne Hezghia; Jeffrey M Miller; Seonjoo Lee; Harry Rubin-Falcone; Thomas B Cooper; Maria A Oquendo; J John Mann; M Elizabeth Sublette Journal: J Psychiatr Res Date: 2016-01-11 Impact factor: 4.791